$9.56
0.42%
Nasdaq, Jan 02, 10:03 pm CET

CryoPort Stock price

$9.56
+0.35 3.80% 1M
+2.12 28.49% 6M
-0.04 0.42% YTD
+1.58 19.80% 1Y
-7.79 44.90% 3Y
-37.49 79.68% 5Y
+7.48 359.62% 10Y
-650.44 98.55% 20Y
Nasdaq, Closing price Fri, Jan 02 2026
-0.04 0.42%

Key metrics

Basic
Market capitalization
$478.7m
Enterprise Value
$244.7m
Net debt
positive
Cash
$421.3m
Shares outstanding
50.1m
Valuation (TTM | estimate)
P/E
8.1 | 6.8
P/S
2.5 | 2.7
EV/Sales
1.3 | 1.4
EV/FCF
negative
P/B
0.9
Financial Health
Equity Ratio
57.1%
Return on Equity
-30.5%
ROCE
-5.5%
ROIC
-12.3%
Debt/Equity
0.4
Financials (TTM | estimate)
Revenue
$190.3m | $176.3m
EBITDA
$-11.5m | $-4.2m
EBIT
$-40.7m | $-41.1m
Net Income
$59.6m | $70.0m
Free Cash Flow
$-35.2m
Growth (TTM | estimate)
Revenue
-15.9% | -22.8%
EBITDA
73.4% | 88.4%
EBIT
44.6% | 38.7%
Net Income
135.8% | 157.0%
Free Cash Flow
2.9%
Margin (TTM | estimate)
Gross
46.6%
EBITDA
-6.0% | -2.4%
EBIT
-21.4%
Net
31.3% | 39.7%
Free Cash Flow
-18.5%
More
EPS
$1.2
FCF per Share
$-0.7
Short interest
7.3%
Employees
1k
Rev per Employee
$210.0k
Show more

Is CryoPort a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

CryoPort Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a CryoPort forecast:

13x Buy
87%
2x Hold
13%

Analyst Opinions

15 Analysts have issued a CryoPort forecast:

Buy
87%
Hold
13%

Financial data from CryoPort

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
190 190
16% 16%
100%
- Direct Costs 102 102
22% 22%
53%
89 89
7% 7%
47%
- Selling and Administrative Expenses 113 113
25% 25%
59%
- Research and Development Expense 17 17
9% 9%
9%
-11 -11
73% 73%
-6%
- Depreciation and Amortization 29 29
3% 3%
15%
EBIT (Operating Income) EBIT -41 -41
45% 45%
-21%
Net Profit 60 60
136% 136%
31%

In millions USD.

Don't miss a Thing! We will send you all news about CryoPort directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

CryoPort Stock News

Positive
Seeking Alpha
about one month ago
Cryoport, Inc. (CYRX) is the leading provider of temperature-controlled supply chain solutions for the rapidly growing cell and gene therapy industry. CYRX supports 745 clinical trials and 19 commercial therapies, with commercial segment revenue up 36% YoY, reflecting accelerating industry adoption. Despite strong growth and a dominant market position, CYRX trades at depressed valuations, offer...
Neutral
GlobeNewsWire
about 2 months ago
Annual Awards Program Recognizes Breakthrough Life Sciences & Biotechnology Innovation Around the World Annual Awards Program Recognizes Breakthrough Life Sciences & Biotechnology Innovation Around the World
Neutral
Seeking Alpha
about 2 months ago
Cryoport, Inc. ( CYRX ) Q3 2025 Earnings Call November 4, 2025 5:00 PM EST Company Participants Jerrell Shelton - Chairman, President & CEO Robert Stefanovich - Senior VP, CFO, Treasurer & Chief Administrative Officer Mark W. Sawicki - Senior VP & Chief Scientific Officer Thomas Heinzen - Vice President of Corporate Development & Investor Relations Conference Call Participants Todd Fromer - Kan...
More CryoPort News

Company Profile

CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Irvine, CA.

Head office United States
CEO Jerrell Shelton
Employees 1,098
Founded 1990
Website www.cryoport.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today